Literature DB >> 14970455

Standardized RT-PCR and the standardized expression measurement center.

James C Willey1, Erin L Crawford, Charles R Knight, K A Warner, Cheryl A Motten, Elizabeth A Herness, Robert J Zahorchak, Timothy G Graves.   

Abstract

Standardized reverse transcriptase polymerase chain reaction (StaRT-PCR) is a modification of the competitive template (CT) RT method described by Gilliland et al. StaRT-PCR allows rapid, reproducible, standardized, quantitative measurement of data for many genes simultaneously. An internal standard CT is prepared for each gene, cloned to generate enough for 10(9) assays and CTs for up to 1,000 genes are mixed together. Each target gene is normalized to a reference gene to control for cDNA loaded in a standardized mixture of internal standards (SMIS) into the reaction. Each target gene and reference gene is measured relative to its respective internal standard within the SMIS. Because each target gene and reference gene is simultaneously measured relative to a known number of internal standard molecules in the SMIS, it is possible to report each gene expression measurement as a numerical value in units of target gene cDNA molecules/ 10(6) reference gene cDNA molecules. Calculation of data in this format allows for entry into a common databank, direct interexperimental comparison, and combination of values into interactive gene expression indices.

Mesh:

Substances:

Year:  2004        PMID: 14970455     DOI: 10.1385/1-59259-751-3:13

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  13 in total

Review 1.  Reliability and reproducibility issues in DNA microarray measurements.

Authors:  Sorin Draghici; Purvesh Khatri; Aron C Eklund; Zoltan Szallasi
Journal:  Trends Genet       Date:  2005-12-27       Impact factor: 11.639

2.  Evaluation of the branched-chain DNA assay for measurement of RNA in formalin-fixed tissues.

Authors:  Beatrice S Knudsen; April N Allen; Dale F McLerran; Robert L Vessella; Jonathan Karademos; Joan E Davies; Botoul Maqsodi; Gary K McMaster; Alan R Kristal
Journal:  J Mol Diagn       Date:  2008-02-14       Impact factor: 5.568

3.  Quality control methods for optimal BCR-ABL1 clinical testing in human whole blood samples.

Authors:  Lauren M Stanoszek; Erin L Crawford; Thomas M Blomquist; Jessica A Warns; Paige F S Willey; James C Willey
Journal:  J Mol Diagn       Date:  2013-03-27       Impact factor: 5.568

4.  Pattern of antioxidant and DNA repair gene expression in normal airway epithelium associated with lung cancer diagnosis.

Authors:  Thomas Blomquist; Erin L Crawford; D'Anna Mullins; Youngsook Yoon; Dawn-Alita Hernandez; Sadik Khuder; Patricia L Ruppel; Elizabeth Peters; David J Oldfield; Brad Austermiller; John C Anders; James C Willey
Journal:  Cancer Res       Date:  2009-11-03       Impact factor: 12.701

5.  Accurate estimates of microarray target concentration from a simple sequence-independent Langmuir model.

Authors:  Raad Z Gharaibeh; Anthony A Fodor; Cynthia J Gibas
Journal:  PLoS One       Date:  2010-12-30       Impact factor: 3.240

6.  Stable low-level expression of p21WAF1/CIP1 in A549 human bronchogenic carcinoma cell line-derived clones down-regulates E2F1 mRNA and restores cell proliferation control.

Authors:  Timothy G Graves; Michael W Harr; Erin L Crawford; James C Willey
Journal:  Mol Cancer       Date:  2006-01-10       Impact factor: 27.401

7.  CEBPG transcription factor correlates with antioxidant and DNA repair genes in normal bronchial epithelial cells but not in individuals with bronchogenic carcinoma.

Authors:  D'Anna N Mullins; Erin L Crawford; Sadik A Khuder; Dawn-Alita Hernandez; Youngsook Yoon; James C Willey
Journal:  BMC Cancer       Date:  2005-10-29       Impact factor: 4.430

8.  ABCC5, ERCC2, XPA and XRCC1 transcript abundance levels correlate with cisplatin chemoresistance in non-small cell lung cancer cell lines.

Authors:  David A Weaver; Erin L Crawford; Kristy A Warner; Fadel Elkhairi; Sadik A Khuder; James C Willey
Journal:  Mol Cancer       Date:  2005-05-09       Impact factor: 27.401

9.  Cross-platform comparison of SYBR Green real-time PCR with TaqMan PCR, microarrays and other gene expression measurement technologies evaluated in the MicroArray Quality Control (MAQC) study.

Authors:  Emi Arikawa; Yanyang Sun; Jie Wang; Qiong Zhou; Baitang Ning; Stacey L Dial; Lei Guo; Jingping Yang
Journal:  BMC Genomics       Date:  2008-07-11       Impact factor: 3.969

10.  Peroxisome proliferator-activated receptor δ agonist, HPP593, prevents renal necrosis under chronic ischemia.

Authors:  Larisa V Fedorova; Komal Sodhi; Cara Gatto-Weis; Nitin Puri; Terry D Hinds; Joseph I Shapiro; Deepak Malhotra
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.